InvestorsHub Logo
Followers 122
Posts 6384
Boards Moderated 0
Alias Born 08/17/2014

Re: None

Thursday, 06/11/2015 11:47:05 PM

Thursday, June 11, 2015 11:47:05 PM

Post# of 34625


This is an 8+ min interview with Keith Knutson about the relationship with TapImmune and the development of the immunotherapy technology. The intention of the vaccines is both to eliminate and keep the cancer from reoccurring in both breast and ovarian cancers. It is a game changer! It potentially eliminates harsh chemo. It was made in partnership with TapImmune's technology. As a reminder TapImmune's technology display the antigens more precisely.

Moderators, can we sticky?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News